Top-News
Verkauf, spezialisiert USA

Barnes Group News

Aktie
WKN:  861254 ISIN:  US0678061096 US-Symbol:  B
35,40 €
+0,40 €
+1,14%
10.05.24 21:43:55
Handeln Depot/Watchlist
Aktienanzahl *
50,96 Mio.
Marktkapitalisierung *
1,82 Mrd. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 15.10.2023

Barnes Group News

07.03.24 - PR Newswire
BioArctic's partner Eisai presents updated sales simulation for Leqembi® at its annual press conference
BioArctic's partner Eisai presents updated sales simulation for Leqembi® at its annual press conference PR Newswire
08.02.24 - PR Newswire
Flexxbotics and Zaptic Win Hexagon's Third 'Sixth Sense' Cohort of Advanced Manufacturing Startups
Flexxbotics and Zaptic Win Hexagon's Third 'Sixth Sense' Cohort of Advanced Manufacturing Startups PR Newswire
07.02.24 - PR Newswire
Sectra continues its winning streak of global customer satisfaction with 5 Best in KLAS awards in 2024
Sectra continues its winning streak of global customer satisfaction with 5 Best in KLAS awards in 2024 PR Newswire
05.02.24 - PR Newswire
ETQ Accelerates Growth, Meets Rising Demand for Automated Quality Management in Fourth Quarter 2023
ETQ Accelerates Growth, Meets Rising Demand for Automated Quality Management in Fourth Quarter 2023 PR Newswire
05.02.24 - PR Newswire
ETQ Accelerates Growth, Meets Rising Demand for Automated Quality Management in Fourth Quarter 2023
ETQ Accelerates Growth, Meets Rising Demand for Automated Quality Management in Fourth Quarter 2023 PR Newswire
20.12.23 - PR Newswire
Integrum establishes Center of Excellence in Ukraine
Integrum establishes Center of Excellence in Ukraine PR Newswire
10.11.23 - PR Newswire
Clinical study of Integrum's OPRA™ Implant System on below-knee amputations will include up to 30 patients and is fully funded by the Department of Defense
Clinical study of Integrum's OPRA™ Implant System on below-​knee amputations will include up to 30 patients and is fully funded by the Department of Defense PR Newswire
09.11.23 - PR Newswire
Integrum publishes preliminary revenue, result and and cash flow figures for Q2, 2023
Integrum publishes preliminary revenue, result and and cash flow figures for Q2, 2023 PR Newswire
08.11.23 - PR Newswire
Tele2 enables sustainable forestry with AirForestry and Nokia 5G Private Wireless
Tele2 enables sustainable forestry with AirForestry and Nokia 5G Private Wireless PR Newswire
27.10.23 - PR Newswire
Integrum moves into Turkey
Integrum moves into Turkey PR Newswire
05.09.23 - PR Newswire
Sectra's three-month interim report 2023/2024: Record-high order bookings
Sectra's three-​month interim report 2023/2024: Record-​high order bookings PR Newswire
23.08.23 - PR Newswire
Invitation to presentation of Sectra's three-month interim report 2023/2024
Invitation to presentation of Sectra's three-​month interim report 2023/2024 PR Newswire
06.07.23 - PR Newswire
Sectra publishes Annual Report and Sustainability Report for 2022/2023
Sectra publishes Annual Report and Sustainability Report for 2022/2023 PR Newswire
21.05.23 - PR Newswire
Marketing Authorisation Application for lecanemab submitted in Great Britain: BioArctic
Marketing Authorisation Application for lecanemab submitted in Great Britain: BioArctic PR Newswire
16.05.23 - PR Newswire
Societal value of lecanemab in Japan published in Neurology and Therapy
Societal value of lecanemab in Japan published in Neurology and Therapy PR Newswire
16.05.23 - PR Newswire
Societal value of lecanemab in Japan published in Neurology and Therapy
Societal value of lecanemab in Japan published in Neurology and Therapy PR Newswire
12.05.23 - PR Newswire
TSX Venture Exchange Stock Maintenance Bulletins
TSX Venture Exchange Stock Maintenance Bulletins Canada NewsWire
01.05.23 - PR Newswire
Grupo Simec Files Its Form 20-F For The 2022 Financial Year
Grupo Simec Files Its Form 20-F For The 2022 Financial Year PR Newswire
03.04.23 - PR Newswire
Long-term health outcomes for lecanemab using simulation model and Phase 3 Clarity AD data published
Long-term health outcomes for lecanemab using simulation model and Phase 3 Clarity AD data published PR Newswire
03.04.23 - PR Newswire
Long-term health outcomes for lecanemab using simulation model and Phase 3 Clarity AD data published
Long-term health outcomes for lecanemab using simulation model and Phase 3 Clarity AD data published PR Newswire

Newssuche

Videos

newspaper
07.05.24 +6,80%
Technical Trading: DAX Long kurzfristig
DAX Long Typ: Turbo Open End WKN: NG8K9X Hebel: 26 Laufzeit: OpenEnd Einstieg: Market ... Mehr »